Yen-Chi Wu
Dr. Laurie Wu is a molecular and genetic scientist and has good tracking record on the study of miRNAs and normal and cancer neural stem cell proliferation regulation. Dr. Wu received her Ph.D. from Indiana University Bloomington with extensive training in the field of RNA on 2014. After graduation, Dr. Wu then started her postdoctoral researcher in Stanford to apply the microRNA technology in therapeutic discovery before she joined BioVision Inc. in 2017. Now her work capacity and interests is to offer novel therapeutic strategies to fight human cancers. In 2017, Dr. Wu joined CBA as volunteer and actively contributed to assist on organizing CBA 20thanniversary conference.